Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: A phase II study with long-term follow-up

European Journal of Gynaecological Oncology

Volumn 19, Issue 6, 1998, Pages 524-528

  Paulsen, T ^a   Kaern, J ^a   Trope C ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NAUSEA; PHASE 2 CLINICAL TRIAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0032414379     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bonomi P., Blessing J. A., Stehman F. B., DiSaia P. J., Walton L., Major F. J.: "Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncolosy Group study". J. Clin. Oncol., 1985, 3, 1079.
2. Kaern J., Tropé C, Sundfoer K., Kristensen G. B.: "Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up". Gynecol. Oncol., 1996, 60, 387.
3. Alberts D. S., Green S., Hannigan E. V., O'Toole R., Stock Novack D., Andersen P., Surwit E. A. et al.: "Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stases III and IV ovarian cancer". J. Clin. Oncol., 1992, 10, 706.
4. Swenerton K., Jeffrey J., Stuart G., Roy M., Krepart G., Carmichael J., Drouin P. et al.: "Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trial Group". J. Clin. Oncol., 1992, 10, 718.
5. World Health Organization. "WHO handbook for reporting results of cancer treatment. Genève". WHO offset publication, 1979, No 48.
6. Kaplan E. L., Meyer P.: "Nonparametric estimation from incomplete observations". J. Am. Stat. Assoc., 1958 53, 457.
7. Tarone R. E., Ware J.: "On distribution-free tests for equality of survival distributions". Biometrika, 1971, 64, 156.
8. Vermerken J. B.: "The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review". Int. J. Gynecol. Cancer, 1993, 3, 129.
9. Levi J. A., Wheeler H. R., Friedlander M., Tattersal M. H., Kefford R., Dalley D.: "Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix". Gynecol. Oncol., 1992, 45, 329.
10. Potter M. E., Hatch K. D., Potter M. Y., Shingleton H. M., Baker V. V.: "Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin". Cancer, 1989, 63, 1283.
11. Wasserman T. H., Carter S.: "The integration of chemotherapy into combined modality treatment of solid tumors: VIII. Cervical cancer". Cancer Treat. Rev., 1977, 4, 25.
12. Rustin G. J., Newlands E. S.: "Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix". Br. J. Cancer, 1988, 58, 818.
13. Sadek H., Azli N., Wendung J. L., Cvitkovic E., Rahal M., Mamelle G., Guillaume J. C. et al.: "Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin". Cancer, 1990, 66, 1692.
14. Alberts D. S., Kronmal R., Baker L. H., Stock Novack D. L., Surwit E. A., Boutselis J. G., Hannigan E. V.: "Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study". J. Clin. Oncol, 1987, 5, 1791.
15. Sundfor K., Tropé C. G., Hogberg T, Onsrud M., Kaern J., Simonsen E., Berteisen K., Westberg R.: "Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A". Cancer, 1996, 77, 2371.
16. Lira Puerto V., Silva A., Morris M., Martinez R., Groshen S., Morales Canfield F., Tenorio F., Muggia F.: "Phase II trial of carboplatin or iproplatin in cervical cancer". Cancer Chemother. Pharmacol., 1991, 28, 391.
17. du Bois A., Vach W, Thomssen C., Karck U., Madjar H., Prompeler H., Meerpohl H. G.: "Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agents". Acta Oncol., 1994, 33, 531.